Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
Patients in phase 2 pilot trial 2-THE-TOP had median progression-free survival of 12.1 months compared…
Patients in phase 2 pilot trial 2-THE-TOP had median progression-free survival of 12.1 months compared…
TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery”…
SYDNEY--(BUSINESS WIRE)--All good things must come to an end and after almost a month of…
Detected 100% of Malware in Testing – Extends Endpoint Leadership RESEARCH TRIANGLE PARK, NC, March…
NEW YORK--(BUSINESS WIRE)--Piedmont Lithium Inc. (“Piedmont” or the “Company”) (Nasdaq:PLL; ASX:PLL) today announced the closing…
Verimatrix’s award-winning Video Content Authority System (VCAS) for DVB Hybrid to be deployed on new…
A behind-the-scenes look at how Nissan is developing safer cars YOKOHAMA, Japan--(BUSINESS WIRE)--Watch video here:…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Digital Health Market Size, Share & Trends Analysis Report by Technology…
MELBOURNE, Australia--(BUSINESS WIRE)--Hansen Technologies (ASX:HSN) is pleased to announce an expansion of its longstanding partnership…
DUBLIN--(BUSINESS WIRE)--The "China Live Streaming E-Commerce Market: Analysis By Product Size & Trends with Impact…